Matthew P. Young

2014

In 2014, Matthew P. Young earned a total compensation of $3.4M as Executive Vice President and CFO at Jazz Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$250,000
Option Awards$1,185,144
Salary$402,904
Stock Awards$1,563,726
Other$3,620
Total$3,405,394

Young received $1.6M in stock awards, accounting for 46% of the total pay in 2014.

Young also received $250K in non-equity incentive plan, $1.2M in option awards, $402.9K in salary and $3.6K in other compensation.

Rankings

In 2014, Matthew P. Young's compensation ranked 2,578th out of 13,032 executives tracked by ExecPay. In other words, Young earned more than 80.2% of executives.

ClassificationRankingPercentile
All
2,578
out of 13,032
80th
Division
Manufacturing
916
out of 4,966
82nd
Major group
Chemicals And Allied Products
285
out of 1,686
83rd
Industry group
Drugs
221
out of 1,365
84th
Industry
Pharmaceutical Preparations
182
out of 1,043
83rd
Source: SEC filing on June 20, 2017.

Young's colleagues

We found five more compensation records of executives who worked with Matthew P. Young at Jazz Pharmaceuticals in 2014.

2014

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2014

Russell Cox

Jazz Pharmaceuticals

Chief Operating Officer

2014

Suzanne Hooper

Jazz Pharmaceuticals

Executive Vice President and GC

2014

Michael Miller

Jazz Pharmaceuticals

Senior Vice President, U.S. Commercial

2014

Kathryn Falberg

Jazz Pharmaceuticals

Chief Financial Officer

News

You may also like